Extended Oral Anticoagulant Therapy after a First Episode of Pulmonary Embolism

Annals of Internal Medicine

Volumn 139, Issue 1, 2003, Pages

  Agnelli, Giancarlo ^a   Prandoni, Paolo ^b   Becattini, Cecilia ^b   Silingardi, Mauro ^b   Taliani, Maria Rita ^b   Miccio, Maddalena ^b   Imberti, Davide ^b   Poggio, Renzo ^b   Ageno, Walter ^b   Pogliani, Enrico ^b   Porro, Fernando ^b   Zonzin, Pietro ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG FATALITY; FATALITY; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEMATURIA; HIGH RISK PATIENT; HUMAN; IDIOPATHIC DISEASE; LONG TERM CARE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE HEMATOMA; OPEN STUDY; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK FACTOR; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; ADOLESCENT; CHEMICALLY INDUCED DISORDER; DRUG ADMINISTRATION; MIDDLE AGED; TREATMENT WITHDRAWAL;

ACENOCOUMAROL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; DRUG ADMINISTRATION SCHEDULE; HEMORRHAGE; HUMANS; MIDDLE AGED; PULMONARY EMBOLISM; RECURRENCE; RISK FACTORS; TREATMENT OUTCOME; WARFARIN; WITHHOLDING TREATMENT;

EID: 1642453712     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-139-1-200307010-00008     Document Type: Article

References (17)

1. Kearon C, Gent M, Hirsh J, Weitz J, Kovacs MJ, Anderson DR, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med. 1999;340:901-7. [PMID: 10089183]
2. Agnelli G, Prandoni P, Santamaria MG, Bagatella P, Iorio A, Bazzan M, et al. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. N Engl J Med. 2001;345:165-9. [PMID: 11463010]
3. Ginsberg JS. Management of venous thromboembolism. N Engl J Med. 1996;335:1816-28. [PMID: 8943165]
4. Lensing AW, Prandoni P, Prins MH, Büller HR. Deep-vein thrombosis. Lancet. 1999;353:479-85. [PMID: 9989735]
5. Hyers TM, Agnelli G, Hull RD, Morris TA, Samama M, Tapson V, et al. Antithrombotic therapy for venous thromboembolic disease. Chest. 2001;119:176S-193S. [PMID: 11157648]
6. Schulman S, Rhedin AS, Lindmarker P, Carlsson A, Lärfars G, Nicol P, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med. 1995;332:1661-5. [PMID: 7760866]
7. Pinede L, Ninet J, Duhaut P, Chabaud S, Demolombe-Rague S, Durieu I, et al. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation. 2001;103:2453-60. [PMID: 11369685]
8. Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA. 1998;279:458-62. [PMID: 9466640]
9. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med. 1999;159:445-53. [PMID: 10074952]
10. Prandoni P, Cogo A, Bemardi E, Villalta S, Polistena P, Simioni P, et al. A simple ultrasound approach for detection of recurrent proximal-vein thrombosis. Circulation. 1993;88:1730-5. [PMID: 8403319]
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association. 1958;53:457-81.
12. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163-70. [PMID: 5910392]
13. Hansson PO, Sörbo J, Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med. 2000; 160:769-74. [PMID: 10737276]
14. Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, Carta M, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125:1-7. [PMID: 8644983]
15. Carson JL, Kelley MA, Duff A, Weg JG, Fulkerson WJ, Palevsky HI, et al. The clinical course of pulmonary embolism. N Engl J Med. 1992;326:1240-5. [PMID: 1560799]
16. Murin S, Romano PS, White RH. Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism. Thromb Haemost. 2002;88:407-14. [PMID: 12353068]
17. Palareti G, Legnani C, Cosmi B, Guazzaloca G, Pancani C, Coccheri S. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped. Thromb Haemost. 2002;87:7-12. [PMID: 11848459]